Benzinga | Feb 10, 2021 04:07PM EST

Pacific Biosciences Q4 EPS $0.37 Beats $0.32 Estimate, Sales $27.14M Beat $25.41M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.32 by 15.62 percent. The company reported quarterly sales of $27.14 million which beat the analyst consensus estimate of $25.41 million by 6.79 percent. This is a 2.84 percent decrease over sales of $27.93 million the same period last year.